Dr. Christopher James Mercogliano, DO

Dr. Mercogliano practices at Virtua Home Care at West Jersey in Marlton, New Jersey.

Dr. Mercogliano's NPI, 1306292966, was assigned on May 12, 2016. Dr. Mercogliano graduated from Lake Erie College of Osteopathic Medicine, Erie in 2016. Dr. Mercogliano holds New Jersey license 25MB10494100.

Dr. Mercogliano's primary practice is Virtua Home Care at West Jersey, at 301 Lippincott Drive - 2nd Floor, Marlton, NJ 08053. The practice phone is (856) 581-7200.

Dr. Mercogliano's primary practice is Virtua Home Care at West Jersey in Marlton, New Jersey. Dr. Mercogliano is also affiliated with Virtua Voorhees Hospital. The medical group on file is Virtua Medical Group. Dmand AI also links Dr. Mercogliano to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Mercogliano's employer is on file too: a home health agency.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mercogliano practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mercogliano's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Mercogliano's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 2,463 Medicare services from Dr. Mercogliano across 19 procedure codes in 2024, for 1,193 Medicare patients. Medicare paid $128,799 for them.

CMS counts 1,193 Medicare patients who saw Dr. Mercogliano in 2024. The largest group is 75 to 84, with 452 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mercogliano's median patient age at 65, with 51% women.

In 2024, Dr. Mercogliano wrote 2,956 Medicare Part D claims for 428 patients. 80% of them were for generic drugs. CMS names the drug for 2,802 of them, across 40 drugs with 11 or more claims each, at $596,401 in total drug cost. In 2023, CMS named 929 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Mercogliano for performance year 2024, reported as part of a group. Dr. Mercogliano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Mercogliano, published from 2018 to 2020. 2018 was the busiest year, with 3. Dr. Mercogliano's most frequent co-authors are Anthony A. Donato, MD, Adam P. Sigal, MD and Ryan D'Souza, DO.

CMS Open Payments shows 100 general payments to Dr. Mercogliano from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Abbott Laboratories paid the most, $1,119.

Dr. Mercogliano graduated from Lake Erie College of Osteopathic Medicine, Erie in 2016.